Description
Ipamorelin operates as a pentapeptide and a highly selective ghrelin receptor agonist. It is notable in research for its high selectivity — stimulating growth hormone release without significantly affecting cortisol, prolactin, or ACTH levels in preclinical studies.
Research Background
It is frequently studied alongside CJC-1295 No DAC due to their synergistic mechanisms on the GH/IGF-1 axis. Research has explored Ipamorelin’s effects on GH pulse amplitude, metabolic function, and body composition in animal models.
Specifications:
- Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Purity: ≥99% (HPLC verified)
- Format: Lyophilised powder
- Quantity: 5mg per vial
Important Notice
This product is supplied strictly for in vitro laboratory research purposes. It is not intended for use in humans or animals. It has not been evaluated by the MHRA, the FDA, or any other regulatory authority for safety or efficacy in any application. This product must not be used as a medicine, food supplement, or cosmetic ingredient. Researchers are responsible for ensuring compliance with all applicable local regulations governing the use of research compounds.
For laboratory research use only. Not for human or veterinary consumption.
Reviews
There are no reviews yet.